
Opinion|Videos|May 7, 2024
Managing Adverse Events Associated with HE Therapies
Ralph J. Riello, PharmD, BCPS, discusses the adverse events associated with hepatic encephalopathy (HE) treatments and the importance of encouraging patients to continue first-line medications despite adverse reactions to prevent HE recurrence.
Advertisement
Episodes in this series

Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Bipartisan Legislation Introduced to Control Drug Prices, ‘Corporate Greed’ Within Health Care
2
FDA Moves to Restrict Mass-Marketed Compounded GLP-1 Products
3
FDA Approves Drug Labeling Changes to 6 Menopausal Hormone Therapy Products
4
Trispecific Antibody IBI3003 Receives Fast Track Designation for Relapsed or Refractory Multiple Myeloma
5








































